Notice of Application - 2012
[Federal Register Volume 77, Number 202 (Thursday, October 18, 2012)]
[Notices]
[Page 64143]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25638]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Noramco, Inc.
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on July 27, 2012, Noramco, Inc.,
500 Swedes Landing Road, Wilmington, Delaware 19801-4417, made
application by renewal to the Drug Enforcement Administration (DEA) as
a bulk manufacturer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Morphine-N-oxide (9307) |
I |
| Amphetamine (1100) |
II |
| Methylphenidate (1724) |
II |
| Phenylacetone (8501) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Hydrocodone (9193) |
II |
| Morphine (9300) |
II |
| Oripavine (9330) |
II |
| Thebaine (9333) |
II |
| Opium extracts (9610) |
II |
| Opium fluid extract (9620) |
II |
| Opium tincture (9630) |
II |
| Opium, powdered (9639) |
II |
| Opium, granulated (9640) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Tapentadol (9780) |
II |
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than December 17, 2012.
Dated: October 9, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-25638 Filed 10-17-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
